Man Group’s Melinta Therapeutics MLNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
– Sell
-30,708
Closed -$1.14M – 2293
2018
Q1
$1.14M Buy
+30,708
New +$2.02M 0.01% 1477

Other funds holding MLNT

Man Group's MLNT Position: Q2 2018 in Review

Man Group sold out of Melinta Therapeutics (MLNT) in Q2 2018, closing a stake of 30,708 shares — an estimated $1.14M sold.

Man Group first reported a position in MLNT in Q1 2018 and held it in 1 quarter. The position peaked at $1.14M in Q1 2018. 87 funds tracked by Wall St. Rank hold MLNT as of Q2 2018.

  • Man Group reported no remaining Melinta Therapeutics position as of Q2 2018 after selling out during the quarter.
  • Man Group sold 30,708 Melinta Therapeutics shares in Q2 2018, an estimated $1.14M.
  • Man Group first reported a position in Melinta Therapeutics in Q1 2018 and held it in 1 quarter.
  • Man Group's Melinta Therapeutics position peaked at $1.14M in Q1 2018.
  • 87 funds tracked by Wall St. Rank held Melinta Therapeutics as of Q2 2018.

Based on Man Group's 13F filing for Q2 2018, filed 14 Aug 2018.